Aurobindo Pharma to launch oncology, respiratory products in US by 2021

The company is also focussing on securing intellectual property (IP) and ramping up and filing of specialty products.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Py9sxc
via IFTTT